These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9536280)

  • 1. Microvessel density, p53 overexpression, and apoptosis in invasive breast carcinoma.
    Gonzalez-Palacios F; Sancho M; Martinez JC; Bellas C
    Mol Pathol; 1997 Dec; 50(6):304-9. PubMed ID: 9536280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.
    Rice AJ; Steward MA; Quinn CM
    J Clin Pathol; 2002 Dec; 55(12):921-5. PubMed ID: 12461058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal uridine nick end labelling and mitosis in breast carcinoma. Correlation with tumor grade and p53 overexpression.
    Dey P; Luthra UK; George SS; Haji BI; George J
    Anal Quant Cytol Histol; 2001 Feb; 23(1):27-30. PubMed ID: 11233740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvessel density and p53 overexpression in young women with breast cancer: a case-control study.
    Kalfon B; Fineberg S; Gu Y; Anand K; Dalal A ; Jones J; Sparano JA
    Clin Breast Cancer; 2001 Apr; 2(1):67-72. PubMed ID: 11899385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma.
    Lu C; Tanigawa N
    Cancer Res; 1997 Jan; 57(2):221-4. PubMed ID: 9000558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.
    McCarthy NJ; Yang X; Linnoila IR; Merino MJ; Hewitt SM; Parr AL; Paik S; Steinberg SM; Hartmann DP; Mourali N; Levine PH; Swain SM
    Clin Cancer Res; 2002 Dec; 8(12):3857-62. PubMed ID: 12473600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive carcinoma of the breast: angiogenesis and cell proliferation.
    Cao Y; Paner GP; Kahn LB; Rajan PB
    Arch Pathol Lab Med; 2004 Aug; 128(8):893-6. PubMed ID: 15270612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between P53 expression and CD34 angiogenic factor in Tunisian breast cancer.
    Fourati A; Khomsi F; El May MV; Rahal K; Gamoudi A; Boussen H; Ben Abdallah M; El May A
    Tunis Med; 2007 Feb; 85(2):105-8. PubMed ID: 17665654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.
    Costa C; Soares R; Reis-Filho JS; Leitão D; Amendoeira I; Schmitt FC
    J Clin Pathol; 2002 Jun; 55(6):429-34. PubMed ID: 12037025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
    Vartanian RK; Weidner N
    Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations and expression in breast carcinoma in situ.
    Lukas J; Niu N; Press MF
    Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
    Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
    J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.
    Vakkala M; Kahlos K; Lakari E; Pääkkö P; Kinnula V; Soini Y
    Clin Cancer Res; 2000 Jun; 6(6):2408-16. PubMed ID: 10873093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
    Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
    BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast.
    Zolota V; Gerokosta A; Melachrinou M; Kominea A; Aletra C; Scopa CD
    Anticancer Res; 1999; 19(4B):3269-74. PubMed ID: 10652623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors.
    Tse GM; Lui PC; Scolyer RA; Putti TC; Kung FY; Law BK; Lau TS; Lee CS
    Mod Pathol; 2003 Oct; 16(10):1007-13. PubMed ID: 14559983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy.
    Colecchia M; Frigo B; Del Boca C; Guardamagna A; Zucchi A; Colloi D; Leopardi O
    J Clin Pathol; 1997 May; 50(5):384-8. PubMed ID: 9215120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin expression and angiogenesis in breast cancers.
    Tökés AM; Hortoványi E; Kulka J; Jäckel M; Kerényi T; Kádár A
    Pathol Res Pract; 1999; 195(12):821-8. PubMed ID: 10631717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis in human hepatocellular carcinoma and in liver cell dysplasia is correlated with p53 protein immunoreactivity.
    Zhao M; Zimmermann A
    J Clin Pathol; 1997 May; 50(5):394-400. PubMed ID: 9215122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Allevi G; Bolsi G; Aguggini S; Brunelli A; Betri E; Generali D; Scaratti L; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2002 Jun; 8(6):1816-21. PubMed ID: 12060622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.